QA: Neurogene Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001404644_2018_Neurogene_Inc.pdf

Logs

Graph

Absolute values for 0001404644, Neurogene Inc

  xvar xval
0 AssetsCurrent 108,825,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 905,000
3 remainder_Assets 599,000
4 LiabilitiesCurrent 10,956,000
5 LiabilitiesNoncurrent 486,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 36,035,409
9 ResearchAndDevelopmentExpense 36,768,087
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 924,853
13 remainder_ComprehensiveNetIncome 106,565
  yvar yval
0 Assets 110,329,000
1 Liabilities 11,442,000
2 Expenses 72,803,496
3 Revenues 0
4 StockholdersEquity 98,887,000
5 NetIncome -71,878,643
6 ComprehensiveNetIncome -71,825,360
7 BaseVar 97,802,957
8 EconomicCapitalRatiobeforeLimitedLiability 2.36
9 EconomicCapitalRatio 3.26

Edgar->Model Mapping

Feature Distribution

Change over Time